5VAO

Crystal structure of eVP30 C-terminus and eNP peptide

External Resource: Annotation

Domain Annotation: SCOP2 Classification
Domain Annotation: ECOD Classification
Domain Annotation: CATH
Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
A	SCOP2B Superfamily	VP30 CTD-like	8052486	3002122	SCOP2B (2022-06-29)
B	SCOP2B Superfamily	VP30 CTD-like	8052486	3002122	SCOP2B (2022-06-29)
C	SCOP2B Superfamily	VP30 CTD-like	8052486	3002122	SCOP2B (2022-06-29)
D	SCOP2B Superfamily	VP30 CTD-like	8052486	3002122	SCOP2B (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	Transcript_VP30	e5vaoA1	A: alpha bundles	X: Minor nucleoprotein VP30 C-terminal domain (From Topology)	H: Minor nucleoprotein VP30 C-terminal domain (From Topology)	T: Minor nucleoprotein VP30 C-terminal domain	F: Transcript_VP30	ECOD (1.6)
B	Transcript_VP30	e5vaoB1	A: alpha bundles	X: Minor nucleoprotein VP30 C-terminal domain (From Topology)	H: Minor nucleoprotein VP30 C-terminal domain (From Topology)	T: Minor nucleoprotein VP30 C-terminal domain	F: Transcript_VP30	ECOD (1.6)
C	Transcript_VP30	e5vaoC1	A: alpha bundles	X: Minor nucleoprotein VP30 C-terminal domain (From Topology)	H: Minor nucleoprotein VP30 C-terminal domain (From Topology)	T: Minor nucleoprotein VP30 C-terminal domain	F: Transcript_VP30	ECOD (1.6)
D	Transcript_VP30	e5vaoD1	A: alpha bundles	X: Minor nucleoprotein VP30 C-terminal domain (From Topology)	H: Minor nucleoprotein VP30 C-terminal domain (From Topology)	T: Minor nucleoprotein VP30 C-terminal domain	F: Transcript_VP30	ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
A	1.20.120.1160	Mainly Alpha	Up-down Bundle	Four Helix Bundle (Hemerythrin (Met), subunit A)		CATH (4.3.0)
B	1.20.120.1160	Mainly Alpha	Up-down Bundle	Four Helix Bundle (Hemerythrin (Met), subunit A)		CATH (4.3.0)
C	1.20.120.1160	Mainly Alpha	Up-down Bundle	Four Helix Bundle (Hemerythrin (Met), subunit A)		CATH (4.3.0)
D	1.20.120.1160	Mainly Alpha	Up-down Bundle	Four Helix Bundle (Hemerythrin (Met), subunit A)		CATH (4.3.0)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A, B, C, D	PF11507	Ebola virus-specific transcription factor VP30 (Transcript_VP30)	Ebola virus-specific transcription factor VP30	-	Family
E, F, G, H	PF05505	Ebola nucleoprotein (Ebola_NP)	Ebola nucleoprotein	-	Family

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B, C, D	Minor nucleoprotein VP30	cation binding transition metal ion binding zinc ion binding ion binding binding metal ion binding small molecule binding RNA binding organic cyclic compound binding nucleic acid binding identical protein binding protein binding	-	viral nucleocapsid viral capsid virion component host cellular component host intracellular part host cell cytoplasm host cell part host intracellular region cellular anatomical entity
E, F, G, H	NP	RNA binding binding organic cyclic compound binding nucleic acid binding	virion assembly viral RNA genome packaging viral process viral life cycle viral genome packaging	protein-containing complex ribonucleoprotein complex viral nucleocapsid viral capsid virion component host cellular component host intracellular part host cell cytoplasm host cell part host intracellular region cellular anatomical entity helical viral capsid

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B, C, D	IPR014459	Transcriptional activator VP30, Filoviridae type	Family
E, F, G, H	IPR008609	Ebola nucleoprotein	Family

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.